Skip to main content
VCbacked
Log inGet Started

Greywolf Therapeutics

Abingdon, United Kingdom

We are advancing novel antigen modulation technology that controls T cells to guide the immune system.

$50.0M raised
May 2024
Series B
BiotechnologyHealth CareTherapeutics

Top Investors

Earlybird Venture CapitalIntermediate Capital GroupOxford Science EnterprisesCanaan PartnersAndera Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Greywolf Therapeutics

How much funding has Greywolf Therapeutics raised?
Greywolf Therapeutics has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in May 2024.
Who are Greywolf Therapeutics's investors?
Greywolf Therapeutics's investors include Earlybird Venture Capital, Intermediate Capital Group, Oxford Science Enterprises, Canaan Partners, Andera Partners.
Where is Greywolf Therapeutics headquartered?
Greywolf Therapeutics is headquartered in Abingdon, United Kingdom.
What does Greywolf Therapeutics do?
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
What stage is Greywolf Therapeutics at?
Greywolf Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Greywolf Therapeutics — Funding & Investors." VCBacked, May 23, 2024, https://www.vcbacked.co/company/greywolf-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Greywolf Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/greywolf-therapeutics
Wikipedia (cite web)
{{cite web |title=Greywolf Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/greywolf-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong